투석을 시작하는 말기 신부전증 환자에서 혈관 내피세포의 기능이상 = Endothelial Dysfunction in ESRD Patients Starting Dialysis Treatment

다국어 초록 (Multilingual Abstract)

Background : Patients with renal failure have increased cardiovascular risk due to accelerated atherosclerosis. Endothelial dysfunction (ED) appears to be an important initiating event in the process of atherogenesis. ED has been reported in patients receiving hemodialysis and peritoneal dialysis. However, there has been no study on ED in Korean ESRD patients starting dialysis treatment. In this study, ED was assessed in patients starting dialysis treatment and the risk factors of ED were analyzed.
Methods : Among the patients diagnosed as terminal-stage renal disease (ESRD) and started dialysis treatment at Severance Hospital of Yonsei University College of Medicine from January, 2005 to December, 2005, 35 patients (ESRD group) (51.7±12.6 years-old, M:F=22:13) underwent Doppler ultrasonography to have their endothelial functions assessed. Flow-mediated dilation (FMD) was used as an index of ED. For the control group, 33 hypertensive patients (55.2±11.4 years-old, M:F=17:16) with normal renal function were selected and FMD was also measured.
Results : FMD was significantly reduced in the ESRD group compared to the control group (3.8±1.9 vs. 4.9±2.4%, p<0.05). When the ESRD group was divided into either DM or non-DM group according to DM status, there was a significant difference in FMD between the two groups (DM, 3.1±1.9%; non-DM, 4.4±1.9%, p<0.05). In the ESRD group, FMD was inversely related to systolic blood pressure, mean arterial pressure, pulse pressure, and DM duration (p< 0.05).
Conclusion : ED was already present in patients at the time of starting dialysis treatment and was more severe in the DM compared the non-DM patients.

참고문헌 (Reference)

1 "지속성 외래 복막투석 환자에서 혈관내피세포 기능이상에 대한 영양상태 및 만성염증의 영향" 23 : 907-919, 2004

2 "당뇨 혈액투석 환자에서 혈관내피세포 기능이상에 영향을 미치는 인자" 24 : 47-56, 2005

3 "vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure" 106 : 3073-3078, 2002

4 "Vascular structural and functional changes in type 2 diabetes mellitus:evidence for the role of abnormal myogenic responsiveness and dyslipidemia" 106 : 3037-3043, 2002

5 "Vascular effects of acute hyperglycemia in humans are reversed by L-arginine" 95 : 1783-1790, 1997

6 "Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease" 38 : 405-416, 2004

7 "Statin therapy improves brachial artery endothelial function in nephritic syndrome" 62 : 550-557, 2002

8 "Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension" 28 : 181-189, 2005

9 "Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease" 19 : 661-667, 2002

10 "Physiology and biochemistry of endothelial function in children with chronic renal failure" 52 : 468-472, 1997

11 "PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation" 40 : 866-871, 2002

12 "Oxidative stress and cardiovascular injury" 108 : 1912-1916, 2003

13 "Oral antioxidant therapy improves endothelial function in type 1 but not type 2 diabetes mellitus" 285 : 2392-2398, 2003

14 "Multiple actions of angiotensin II in hypertension" 42 : 911-913, 2003

15 "Long-term cardiac morbidity and mortality during dialysis therapy" 23 : 311-330, 1994

16 "Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients" 41 : 616-623, 2003

17 "Kidney transplantation improves endothelium- dependent vasodilation in patients with end stage renal disease" 75 : 1907-1910, 2003

18 "Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function" 282 : 2167-2172, 2002

19 "Inflammation as a mediator of the link between mild to moderated renal insufficiency and endothelial dysfunction in essential hypertension" 17 : 64-68, 2006

20 "Inflammation and atherosclerosis in end-stage renal disease" 21 : 29-36, 2003

21 "Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity" 18 : 892-898, 2003

22 "Endothelium-dependent vasodilation is impaired in peritoneal dialysis patients" 13 : 1782-1786, 1998

23 "Endothelium-dependent vasodilation and distensibility of large arteries in chronic haemodialysis patients" 12 : 14-18, 1997

24 "Endothelial function, CRP and oxidative stress in chronic kidney disease" 18 : 721-726, 2005

25 "Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency" 17 : 537-545, 2006

26 "Endothelial dysfunction and inflammation in asymptomatic proteinuria" 63 : 624-633, 2003

27 "Endothelial dysfunction" 15 : 1983-1992, 2004

28 "Dose oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure?" 105 : 1810-1815, 2002

29 "Demonstration that C-reactive protein decreases eNOS espression and bioactivity in human aortic endothelial cells" 106 : 1439-1441, 2002

30 "Clinical epidemiology of cardiovascular disease in chronic renal disease" 32 : 112-119, 1998

31 "Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease" 59 : 1466-1472, 2001

32 "Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster" 308 : 109-120, 2002

33 "Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes" 87 : 432-438, 1991

34 "Acute effects of haemodialysis on endothelial function and large artery elasticity" 16 : 1663-1668, 2001

35 "Abnormalities of endothelial function in patients with predialysis renal failure" 83 : 205-209, 2000

36 "Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension" 22-27, 1990